Please try another search
For the three months ended 31 March 2022, Medifron DBT Co., Ltd. revenues increased 8% to W10.93B. Net loss before extraordinary items totaled W955.6M vs. income of W229.1M. Revenues reflect F&B Division segment increase from W1.21B to W2.49B, Overseas segment increase from W523.4M to W1.2B. Net loss reflects IT Business segment income decrease of 59% to W277.9M, F&B Division segment income decrease of 98% to W7.7M.
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 10928.86 | 11594.18 | 14727.82 | 11634 |
Gross Profit | 1859.93 | 2646.07 | 2013.59 | 1717.4 |
Operating Income | -859.24 | -7410.38 | 44.53 | 151.83 |
Net Income | -955.6 | -7983.37 | 190.02 | 207.53 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 48476.26 | 49097.28 | 57535.89 | 53242.13 |
Total Liabilities | 7141.49 | 6806.9 | 7039.75 | 2936.01 |
Total Equity | 41334.77 | 42290.37 | 50496.14 | 50306.12 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -1548.86 | -1502.58 | -5664.55 | -4795.62 |
Cash From Investing Activities | -84.62 | -12879.36 | -11723.33 | -11042.82 |
Cash From Financing Activities | -71.77 | 10597.67 | 10673.15 | 6781.51 |
Net Change in Cash | -1687.38 | -3779.92 | -6655.3 | -9049.33 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review